Enter questions for the speakers in the Slido window below. To claim continuing education credit (CME, CHES, and CPH) through APHA for this event, complete this survey by 5:00 pm Eastern.
Don’t miss the next event in the Health in the Headlines series! Regulating a “Miracle Drug”: GLP-1 Costs, Access, & Safety takes place October 8. Register now!
What Should Kids Eat? Ultra-Processed Foods & Children’s Health
This back-to-school season, school nutrition is in the spotlight once again. Federal health officials recently pledged that the newest edition of the U.S. Dietary Guidelines will drive “major, dramatic changes in school food.” This effort is part of a longstanding debate around the role of “ultra-processed foods” in the American diet.
Ultra-processed foods usually have more added sugars and carbohydrates and less protein, fiber, and vitamins than unprocessed or minimally processed foods and are linked to weight gain and related health problems. Research suggests that up to 67 percent of what kids eat in the United States is ultra-processed.
Tune in to a virtual conversation and audience Q&A with leading nutrition experts to explore what we do and don’t know about the impact of ultra-processed foods on children’s health and get practical advice to support good eating habits for American kids.
Agenda
3:00 pm | Welcome
3:05 | Discussion
- Megan Ranney (Moderator), Dean, Yale School of Public Health
- Christopher Gardner, Director of Nutrition Studies, Stanford University
- Kevin Hall, author of Food Intelligence, and former Senior Investigator, National Institutes of Health
- Susan Mayne, former Director, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration
- Fatima Cody Stanford, pediatrician and professor, Harvard Medical School, and member of the 2025 Dietary Guidelines Advisory Committee
3:50 | Audience Q&A
4:25 | Closing Remarks
4:30 | Adjourn
Conflict-of-Interest Disclosures
The following speakers have no relevant financial relationships to disclose: Ranney, Gardner, and Mayne.
Stanford has disclosed relevant financial relationships with Eli Lilly (research, consultant), Novo Nordisk (consultant), Amgen (consultant), Boehringer Ingelheim (consultant), AstraZeneca (consultant), and Currax (consultant). All relevant financial relationships have been mitigated.
Hall has disclosed relevant financial relationships with AstraZeneca (consultant), Zealand Pharma (consultant), and Weight Watchers (consultant). All relevant financial relationships have been mitigated.
*All relevant financial relationships for individuals in a position to control educational content have been identified and mitigated to ensure balance, independence, objectivity, and scientific rigor in this accredited continuing education activity.
Health in the Headlines
This event is part of the National Academy of Medicine’s Health in the Headlines series, which investigates high-profile health and health policy topics making the news. Co-chaired by Alex Azar, former HHS Secretary, and Megan Ranney, Dean of the Yale School of Public Health, the series creates space for nuanced discussion and respectful debate among a diverse set of experts. Series guests are encouraged to distinguish clearly between empirical evidence and personal, cultural, or policy values that may shape their interpretation of the science.
Disclaimer
The National Academy of Sciences, National Academy of Engineering, and National Academy of Medicine—collectively, the National Academies—are independent, non-partisan, and tax exempt. The mission of the National Academies is the provision of trusted, evidence-based advice. It is essential to the execution of the mission that participants in our meetings or events avoid political or partisan statements or commentary and maintain a culture of mutual respect. Statements and presentations made are solely those of the individual participants and do not necessarily represent the views of other participants or the National Academies.
